#ICYMI: @myESMO hosted its annual conference to present the most influential oncology research developments, including results in breast cancer. Read @NBCCStopBC’s review of the #DESTINY-Breast03 trial of Enhertu in metastatic HER2+ breast cancer. stopbreastcancer.org/call-to-action…